TransEntrix soars after it posts smaller than expected 1Q loss on surging sales of its surgical robots
The North Carolina company is targeting higher sales of its Senhance System, a new robotically-assisted surgical device in the second quarter
Sector
1090 stories · page 55 of 55
The North Carolina company is targeting higher sales of its Senhance System, a new robotically-assisted surgical device in the second quarter
Analyst Leah Rush Cann says there could be ‘significant upside’ if the biotech gets a ‘stronger patent foothold’ for CRISPR technology
More than 2 million shares will be offered at US$16 apiece
OptiBiotix Health Plc (LON:OPTI) focuses on managing and treating widespread, chronic medical conditions, such as obesity and high cholesterol, through the modulation of the human microbiome.
WideCells Group PLC ( LON:WDC) was originally set-up in 2012 in Portugal, as a provider of stem cell storage services for the Portuguese and Spanish markets. In 2016 the company was listed on the London Stock Exchange, raising £1.7mln - net
Preventing and treating diseases through the modulation of the microbiome is one of the most exciting frontiers of healthcare, and a fast growing market OptiBiotix Health PLC (LON:OPTI), an innovative life sciences company focused on human
1H 2017 INTERIM RESULTS Judges Scientific Plc (LON:JDG) reported strong 1H 2017 results delivering record figures across revenues, adjusted profit before tax, adjusted earnings per share, and dividends. The management expects to meet the cu
Judges Scientific (JDG.LON) stands out as a unique player of consolidating scientific instruments market. With its extensive acquisitive history over the past 10 years and combined expertise of highly experienced management teams at both th
Judges Scientific (JDG.LON) stands out as a unique player of consolidating scientific instruments market. With its extensive merger history over the past 10 years and combined expertise of highly experienced management teams at both the par
Concepta is a small UK-based company that focuses on the development and commercialization of its medical diagnostic device MyLotus. The device, a consumer good, has been developed to improve the probability of conception for women with une